Abstract
Factor XIII (FXIII) is an essential coagulation factor that stabilizes fibrin clots and allows the clot to resist fibrinolysis. Inherited or acquired FXIII deficiency is a severe bleeding disorder with manifestations that can include fatal intracranial hemorrhage. Accurate FXIII laboratory testing is necessary for diagnosis, subtyping, and treatment monitoring. The recommended first-line test is FXIII activity, most commonly performed by commercial ammonia release assays. In these assays, it is important to perform a plasma blank measurement to correct for FXIII-independent ammonia production, which can lead to clinically significant overestimation of FXIII activity. Automated performance of a commercial FXIII activity assay (Technoclone, Vienna, Austria), including blank correction, on the BCS XP instrument is described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Dorgalaleh A, Tabibian S, Hosseini MS et al (2016) Diagnosis of factor XIII deficiency. Hematology 21(7):430–439
Yan MTS, Rydz N, Goodyear D, Sholzberg M (2018) Acquired factor XIII deficiency: a review. Transfus Apher Sci 57(6):724–730
Biswas A, Ivaskevicius V, Thomas A, Oldenburg J (2014) Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms. Hamostaseologie 34(2):160–166
Alavi SER, Jalalvand M, Assadollahi V, Tabibian S, Dorgalaleh A (2018) Intracranial hemorrhage: a devastating outcome of congenital bleeding disorders-prevalence, diagnosis, and management, with a special focus on congenital factor XIII deficiency. Semin Thromb Hemost 44(3):267–275
Karimi M, Peyvandi F, Naderi M, Shapiro A (2018) Factor XIII deficiency diagnosis: challenges and tools. Int J Lab Hematol 40(1):3–11
Kohler HP, Ichinose A, Seitz R et al (2011) Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost 9(7):1404–1406
Menegatti M, Palla R, Boscarino M et al (2017) Minimal factor XIII activity level to prevent major spontaneous bleeds. J Thromb Haemost 15(9):1728–1736
Muszbek L, Katona E, Kerenyi A (2017) Assessment of factor XIII. Methods Mol Biol 1646:277–293
Dorgalaleh A, Farshi Y, Alizadeh SH et al (2015) Challenges in implementation of ISTH diagnostic algorithm for diagnosis and classification of factor XIII deficiency in Iran. J Thromb Haemost 13(9):1735–1736
Hsu P, Zantek ND, Meijer P et al (2014) Factor XIII Assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of International Proficiency testing results. Semin Thromb Hemost 40(2):232–238
Jennings I, Kitchen S, Woods TA, Preston FE, Uk N (2003) Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost 1(12):2603–2608
Durda MA, Wolberg AS, Kerlin BA (2018) State of the art in factor XIII laboratory assessment. Transfus Apher Sci 57(6):700–704
Schroeder V (2020) Laboratory assessment of coagulation factor XIII. Hamostaseologie 40(4):467–471
Karimi M, Bereczky Z, Cohan N, Muszbek L (2009) Factor XIII deficiency. Semin Thromb Hemost 35(4):426–438
CLSI (2008) Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline, CLSI document H21-A5, 5th edn. Clinical and Laboratory Standards Institute, Wayne
CLSI (2007) Procedures for the collection of diagnostic blood specimens by venipuncture; approved standard, CLSI document H3-A6, 6th edn. Clinical and Laboratory Standards Institute, Wayne
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Smock, K.J., Moser, K.A. (2023). Automation of a Factor XIII Activity Assay Utilizing a Plasma Blank Measurement. In: Favaloro, E.J., Gosselin, R.C. (eds) Hemostasis and Thrombosis. Methods in Molecular Biology, vol 2663. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3175-1_46
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3175-1_46
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3174-4
Online ISBN: 978-1-0716-3175-1
eBook Packages: Springer Protocols